China's ABclonal bags $189m in Series D funding co-led by Sequoia Capital China
China Merchants Bank’s CMB International, and Lucion Venture Capital co-led the investment round.
United States Yurogen Biosystems Oriza Fofs Protein Technology China Merchants Bank Abclonal Technology
Source: dealstreetasia.com